Skip to Main Content

Paper Details

High caspase 3 and vulnerability to dual BCL2 family inhibition define ETO2::GLIS2 pediatric leukemia.
Leukemia
3
2023
AML, BCL2, BCL2 family, BCL2 family members, CASP3, ETO2, GLIS2, GLIS2 fusion oncogene, GLIS2 leukemic cells, MCL1, Patient, Patient-, Pediatric acute myeloid leukemia, caspase 3, human, human cells, leukemia, leukemic, leukemic cell, patient, pediatric, pediatric leukemia, pro-apoptotic CASP3
Author NameAffiliation
Anton M JettenNational Institute of Environmental Health Sciences, National Institutes of Health
Anton M JettenNational Institute of Environmental Health Sciences, National Institutes of Health
Soheil MeshinchiClinical Research Division, Fred Hutchinson Cancer Research Center
Soheil MeshinchiClinical Research Division, Fred Hutchinson Cancer Research Center
Patrick AubergerUniversite Cote d'Azur, INSERM U1065/C3M
Patrick AubergerOPALE Carnot Institute
Camille LobryINSERM U1170, Universite Paris Saclay
Camille LobryINSERM U944, CNRS UMR7212, Institut de Recherche Saint Louis and Universite de Paris
Arnaud JacquelUniversite Cote d'Azur, INSERM U1065/C3M
  • 1 - 9

Datasets

Release 1.2